Access To Answers: A Conversation With Goodwin And Cambridge Innovation Capital – Part 2: The Funding Landscape

Goodwin meets up with Cambridge Innovation Capital (CIC) for a miniseries to discuss hot topics and practical tips for entrepreneurs and start-ups in the technology and life sciences industries.*

In this episode, Roshni and Carol discuss the changing funding landscape that has occurred during lockdown, including:

• Available funding options and how companies can extend their cash runway
• The Future Fund Government Scheme
• How the funding landscape is continuously changing
• Key areas in which investors are focusing their efforts

Stay tuned for our upcoming episode on enhancing your VC relationships.

PARTICIPANTS:

Roshni Thakkar – Roshni is an associate in Goodwin’s technology and life sciences groups and primarily advises clients on transactions in the life sciences, healthcare and technology sectors, in particular in relation to venture capital investments and growth capital. She can be reached at rthakkar@goodwinlaw.com.

Carol Cheung – Carol is a Principal at Cambridge Innovation Capital (CIC) focusing on a range of technology investments. Prior to joining CIC, she worked in a variety of roles at several UK-based early stage technology companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. She has a background in financial analysis gained from working in both the UK and Canada. She holds a B. Comm from the University of Toronto, an MBA from the University of Cambridge’s Judge Business School, and is a CFA charterholder. She can be reached at Carol.Cheung@cic.vc.

* These episodes are conversations about rapidly-changing issues and should not be construed as legal advice because we are not considering the facts of your specific situation. If you have a particular situation on which you need advice, please do not hesitate to contact us using the information above.

****

Please visit Goodwin’s Coronavirus Knowledge Center, where firm lawyers from across the globe are issuing new guidance and insights to help clients fully understand and assess the ramifications of COVID-19 and navigate the potential effects of the outbreak on their businesses.